FitLife Brands Announces First Quarter 2024 Results

$FTLF
Medicinal Chemicals and Botanical Products
Health Care
Get the next $FTLF alert in real time by email

Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2024.

Highlights for the first quarter ended March 31, 2024 include:

  • Total revenue was $16.5 million, an increase of 54% compared to the first quarter of 2023.  
  • Online sales were $10.8 million, representing 65% of total revenue and an increase of 116% compared to the first quarter of 2023.
  • Gross margin was 44.0% compared to 41.1% during the first quarter of 2023.
  • Net income for the first quarter of 2024 was $2.2 million compared to $0.2 million during the same period last year.
  • Basic earnings per share and diluted earnings per share were $0.47 and $0.43, respectively, compared to $0.03 during the first quarter of 2023.
  • Adjusted EBITDA was $3.6 million, a 62% increase compared to the first quarter of 2023.
  • The Company ended the quarter with $16.5 million outstanding on its term loans and cash of $3.3 million, or total net debt of $13.2 million.



For the first quarter ended March 31, 2024, total revenue was $16.5 million, an increase of 54% compared to $10.7 million during the same period last year. Online revenue for the quarter was $10.8 million, an increase of 116% compared to the quarter ended March 31, 2023. Online sales for legacy FitLife increased 3% during the quarter compared to the same period last year. Online revenue accounted for 65% and 47% of the Company's total revenue during the quarters ended March 31, 2024 and 2023, respectively.

Wholesale revenue for the quarter ended March 31, 2024 was $5.7 million, flat when compared to the same period last year.   The Company's recent acquisitions contributed $1.2 million of wholesale revenue during the first quarter of 2024, while Legacy FitLife wholesale revenue was down $1.2 million, or 21%, compared to the same period last year.  

Gross margin for the quarter ended March 31, 2024 was 44.0% compared to 41.1% during the same period in the prior year. Excluding the impact of the inventory step-up resulting from the acquisition of Mimi's Rock Corp ("MRC"), gross margin during the quarter ended March 31, 2023 would have been 42.1%.

Net income for the first quarter of 2024 was $2.2 million compared to $0.2 million during the quarter ended March 31, 2023. Basic earnings per share and diluted earnings per share were $0.47 and $0.43 respectively, compared to $0.03 during the first quarter of 2023. Net income during the first quarter of 2023 was adversely impacted by a number of acquisition-related items that did not recur in 2024 including transaction expenses of $1.4 million, amortization of the inventory step-up valuation of $0.1 million, and a loss on a currency hedge of $0.1 million.

Adjusted EBITDA for the quarter ended March 31, 2024 was $3.6 million, an increase of 62% compared to the same period in 2023.  

The Company ended the quarter with $16.5 million outstanding on its term loans and cash of $3.3 million, or total net debt of $13.2 million. As previously disclosed, the Company made a voluntary paydown on its term loan of $2.5 million during the first quarter of 2024 in addition to the scheduled amortization payment of $1.1 million.

Dayton Judd, the Company's Chairman and CEO, commented "The Company is off to a solid start in 2024 and there are many bright spots in our business. At MRC, I am encouraged that the Dr. Tobias brand—which represents approximately 90% of the MRC business—returned to growth during the quarter despite advertising spend that was 39% lower than in the first quarter of 2023. And although the skin care brands continue to struggle on the top line, they are more profitable now than they were at the time of the acquisition. In total, MRC is significantly more profitable than when we made the acquisition.

"Our legacy FitLife brands continue to face headwinds in the wholesale channel due to declining foot traffic at our brick-and-mortar retail partners. Although the declines were partially offset by growth in the legacy FitLife online business, the online growth rate we experienced during the first quarter was lower than anticipated. We are encouraged, though, that the growth rate for legacy FitLife online sales was much stronger during April with a 13% year-over-year increase.

"In addition, I am excited about a number of new products that we will be introducing this year across several of our brands. Of note, we recently re-launched the MusclePharm Combat Sport protein bar in April 2024. We believe the MusclePharm brand is our most significant organic growth opportunity. Both online and wholesale revenue for MusclePharm ramped up throughout the quarter, and we hope to continue the momentum. Overall, our first quarter results demonstrate that we are continuing to execute our goal of profitably growing revenue and paying down debt."

The Company will hold an investor conference call on Tuesday, May 14, 2024 at 4:30 pm ET. Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 629005. International participants can dial (973) 528-0163 and provide the same code.

About FitLife Brands

FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through approximately 16,000 additional domestic retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.

Forward-Looking Statements

Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Non-GAAP Financial Measures 

  

The financial presentation below contains certain financial measures defined as "non-GAAP financial measures" by the SEC, including non-GAAP EBITDA and non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. 

  

As presented below, non-GAAP EBITDA excludes interest, income taxes, and depreciation and amortization and foreign currency gain/loss. Adjusted non-GAAP EBITDA excludes—in addition to interest, taxes, depreciation and amortization—equity-based compensation, M&A/integration expense, restatement-related expense and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expense and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation below allows investors to compare the Company's financial results with the Company's historical financial results and is an important measure of the Company's comparative financial performance. 



 

 

FITLIFE BRANDS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

  March 31, 2024  December 31, 2023 
  (Unaudited)     
ASSETS:        
CURRENT ASSETS        
Cash and cash equivalents $2,540  $1,139 
Restricted cash  750   759 
Accounts receivable, net of allowance of doubtful accounts of $18 and $17, respectively  2,269   2,046 
Inventories, net of allowance for obsolescence of $139 and $162, respectively  8,869   9,091 
Sales tax receivable  113   1,019 
Prepaid expense and other current assets  451   639 
Total current assets  14,992   14,693 
         
Property and equipment, net  121   137 
Right of use asset  96   121 
Intangibles, net of amortization of $124 and $113, respectively  26,325   26,309 
Goodwill  13,340   13,294 
Deferred tax asset  612   792 
TOTAL ASSETS $55,486  $55,346 
         
LIABILITIES AND STOCKHOLDERS' EQUITY:        
CURRENT LIABILITIES:        
Accounts payable $3,978  $3,261 
Accrued expense and other liabilities  1,397   1,026 
Income taxes payable  1,356   892 
Product returns  524   571 
Term loan – current portion  4,500   4,500 
Lease liability - current portion  73   87 
Total current liabilities  11,828   10,337 
         
Term loan, net of current portion and unamortized deferred finance costs  11,894   15,509 
Long-term lease liability, net of current portion  34   51 
Deferred tax liability  2,353   2,413 
TOTAL LIABILITIES  26,109   28,310 
         
STOCKHOLDERS' EQUITY:        
Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of March 31, 2024 and December 31, 2023  -   - 
Common stock, $0.01 par value, 60,000 shares authorized; 4,598 issued and outstanding as of March 31, 2024 and December 31, 2023  46   46 
Additional paid-in capital  30,801   30,699 
Accumulated deficit  (1,257)  (3,417)
Foreign currency translation adjustment  (213)  (292)
TOTAL STOCKHOLDERS' EQUITY  29,377   27,036 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $55,486  $55,346 

FITLIFE BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(In thousands, except per share data)

(Unaudited)

  Three months ended March 31, 
  2024  2023 
         
Revenue $16,549  $10,738 
Cost of goods sold  9,262   6,330 
Gross profit  7,287   4,408 
         
OPERATING EXPENSE:        
Selling, general and administrative  3,736   2,344 
Merger and acquisition related expense  134   1,372 
Depreciation and amortization  36   19 
Total operating expense  3,906   3,735 
         
OPERATING INCOME  3,381   673 
         
OTHER EXPENSE (INCOME)        
Interest income  (5)  (84)
Interest expense  414   98 
Foreign exchange (gain) loss  5   82 
Total other expense (income)  414   96 
         
INCOME BEFORE INCOME TAX PROVISION  2,967   577 
         
PROVISION FOR INCOME TAXES  807   421 
         
NET INCOME $2,160  $156 
         
NET INCOME PER SHARE        
Basic $0.47  $0.03 
Diluted $0.43  $0.03 
Basic weighted average common shares  4,598   4,483 
Diluted weighted average common shares  5,030   4,935 
         
COMPREHENSIVE INCOME:        
NET INCOME $2,160  $156 
Foreign currency translation adjustment  79   - 
Comprehensive income $2,239  $156 

FITLIFE BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(In thousands)

(Unaudited)

  Three months ended March 31, 
  2024  2023 
         
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income $2,160  $156 
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization  36   19 
Allowance for doubtful accounts  1   (14)
Allowance for inventory obsolescence  (23)  2 
Stock compensation expense  102   42 
Amortization of deferred financing costs  10   1 
Changes in operating assets and liabilities:        
Accounts receivable - trade  (242)  (917)
Inventories  218   1,501 
Deferred tax asset  180   251 
Prepaid expense, other assets and sales tax receivable  1,067   (44)
Right of use asset  21   16 
Accounts payable  727   (1,045)
Lease liability  (30)  (16)
Accrued liabilities, other liabilities and income taxes payable  856   289 
Product returns  (47)  (9)
Net cash provided by operating activities  5,036   232 
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of property and equipment  (10)  - 
Cash paid for acquisition of Mimi's Rock Corp.  -   (17,099)
Net cash used in investing activities  (10)  (17,099)
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Payments on term loans  (3,625)  - 
Borrowings on term loan  -   12,500 
Net cash provided by (used in) financing activities  (3,625)  12,500 
         
Foreign currency impact on cash  (9)  17 
         
CHANGE IN CASH AND RESTRICTED CASH  1,392   (4,350)
CASH, BEGINNING OF PERIOD  1,898   13,277 
CASH AND RESTRICTED CASH, END OF PERIOD $3,290  $8,927 





investor@fitlifebrands.com

Primary Logo

Get the next $FTLF alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FTLF

DatePrice TargetRatingAnalyst
3/17/2025$21.00Buy
Lake Street
9/3/2024$40.00Buy
ROTH MKM
More analyst ratings

$FTLF
Press Releases

Fastest customizable press release news feed in the world

See more
  • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

    Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
  • FitLife Brands Announces its Participation at the 37th Annual Roth Conference and Provides Financial and Operational Update

    Omaha, NE, March 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025.  Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative. In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.  The Company plans to repor

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
  • FitLife Brands Announces Fourth Quarter Earnings Call

    Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133626.  International participants can dial (973) 528-0163 and provide t

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

$FTLF
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$FTLF
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$FTLF
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$FTLF
SEC Filings

See more

$FTLF
Leadership Updates

Live Leadership Updates

See more
  • LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components

$FTLF
Financials

Live finance-specific insights

See more
  • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

    Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
  • FitLife Brands Announces Fourth Quarter Earnings Call

    Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133626.  International participants can dial (973) 528-0163 and provide t

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
  • FitLife Brands Responds to Investor Questions Regarding Registration Statement

    OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today responds to questions from investors regarding its filing of a registration statement with the SEC. On Thursday, November 14th, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC.  On its earnings call, the Company addressed the filing of the S-3.  In response to investor questions, the Company is repeating the information provided by management on the earnings call.  In his prepared remarks during the conference call, the Company's CEO, Dayton Judd, stated

    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care